Veracyte (VCYT) Tops Q2 EPS by 8c, Beats on Revenue; Offers FY24 Revenue Guidance

Veracyte (NASDAQ: VCYT) reported Q2 EPS of $0.07, $0.08 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $114.4 million versus the consensus estimate of $100.27 million.

GUIDANCE:

Veracyte sees FY2024 revenue of $432-438 million, versus the consensus of $406.3 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
• Alphabet to replace Verizon in the Dow Jones Industrial Average